approval
saveNALBUPHINE HYDROCHLORIDE — FDA approval
community read0 votes
Sponsor: RISING. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
same company · ±60 days · 6
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalDec 15, 2023
- approvalsufentanil citrate: SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approvalDec 15, 2023
- approvalBUTORPHANOL TARTRATE: BUTORPHANOL TARTRATE — FDA approvalDec 15, 2023
- approvalalfentanil hydrochloride: ALFENTA (ALFENTANIL HYDROCHLORIDE) — FDA approvalDec 15, 2023
- approvalacetaminophen ER: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 15, 2023
- approvalEffentora: SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approvalDec 15, 2023
comments(0)
5-min edit window · permanent after that